Lee JM, Seo JH, Kim YJ, Kim YS, Ko HJ, Kang CY. The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treat - ment. Int J Cancer . 2012;131(3):741–751. 33. Song X, et al. A tritherapy combination of a fusion protein vaccine with immune-modulating doses of sequential chemotherapies in an optimized regimen completely eradicates large tumors in mice. Int J Cancer . 2011;128(5):1129–1138. 34. Kotsakis A, Harasymczuk M, Schilling B, Geor- goulias V, Argiris A, Whiteside TL. Myeloid- The Journal of Clinical Investigation CLINICAL MEDICINE 6337 jci.org Volume 130 Number 12 December 2020 derived suppressor cell measurements in fresh and cryopreserved blood samples. J Immunol Methods . 2012;381(1-2):14–22. 35. Albeituni SH, Ding C, Yan J. Hampering immune suppressors: therapeutic targeting of myeloid- derived suppressor cells in cancer. Cancer J . 2013;19(6):490–501. 36. Lobon-Iglesias MJ, et al. Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients? J Neuroon- col. 2018;137(1):111–118. 37 . Yang F, Li Y, Zhang Q, Tan L, Peng L, Zhao Y. The effect of immunosuppressive drugs on MDSCs in transplantation. J Immunol Res. 2018;2018:5414808. 38.